Gut microbiome research may transform cancer prevention and treatment by shaping immunity, tumor development and therapy response

You can spend decades building a family's wealth plan. Every tax exposure mapped, every succession scenario modeled, every asset protected. And then someone falls, or forgets, or gets a diagnosis on a Tuesday afternoon, and none of it matters as much as who shows up at the house.

The truth is that most families don’t realize how broken the healthcare system is until they find themselves right in the middle of it. Doctors stop communicating, medications pile up, and you’re left juggling your loved one’s care with no support, no clear guidance, and no one truly in charge.

Modern treatment reframes addiction as a metabolic disorder rooted in energy dysregulation, inflammation, and dopamine imbalance. GLP-1 receptor agonists—originally for diabetes—restore insulin sensitivity, modulate dopamine, and reduce cravings across substances, bridging metabolic health and addiction recovery. Carrara’s stepwise model—Stabilize → Strengthen → Optimize—integrates GLP-1 therapy, targeted labs, structured exercise, and precision peptide treatments.